In this new role, Dr. Bernstein will support the company’s efforts to bring Remimazolam to the U.S. market. Remimazolam is an ultra-short-acting anesthetic.
Dr. Bernstein also serves as the director of the Center for Liver Diseases at North Shore LIJ Health System and professor of medicine at Hofstra North Shore LIJ School of Medicine.
More articles on gastroenterology:
What qualities should young GI physicians look for in a mentor?
GI physician leader to know: Dr. Gary Lichtenstein of Penn Medicine
ASGE recognizes Exeter Hospital: 4 takeaways
